首页> 美国卫生研究院文献>Nanobiomedicine >Development in vitro and in vivo evaluations of novel lipid drug delivery system of Newbouldia laevis (P. Beauv.)
【2h】

Development in vitro and in vivo evaluations of novel lipid drug delivery system of Newbouldia laevis (P. Beauv.)

机译:Newbouldia laevis(P. Beauv。)新型脂质药物递送系统的开发体外和体内评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Newbouldia laevis (P. Beauv.) is a tropical rainforest plant used in traditional folk medicine for the treatment of malaria, cough, joint pains, stomach ache, oedema and inflammation. The main thrust of this research work was to study the analgesic/anti-nociceptive properties of N. laevis-loaded solid lipid microdispersions. N. laevis leaves were extracted using ethanol, and the extract was formulated into solid lipid microdispersions using lipid matrix comprising a rational blend of Precirol® ATO 5 and Softisan® 154. Characterization of the solid lipid microdispersions include determination of morphology, particle size, pH, thermal property, encapsulation efficiency percentage and analgesic/anti-nociceptive property. The results obtained showed that the particles were spherical with sizes ranging from 40 µm to 125 µm. The solid lipid microdispersions maintained a stable pH within the acidic region of 5–6 with insignificant variations (p > 0.05) over a period of 90 days. Thermal analysis showed that N. laevis was entrapped in the lipid matrix used for the formulations. Solid lipid microdispersions recorded a maximum encapsulation efficiency up to 88.1%. N. laevis-loaded solid lipid microdispersions also produced good analgesic/anti-nociceptive property comparable with the standard diclofenac potassium. N. laevis-loaded solid lipid microdispersions showed good analgesic/anti-nociceptive effect and could be used in the treatment and management of pain.
机译:Newbouldia laevis(P. Beauv。)是一种热带雨林植物,用于传统民间医学中,用于治疗疟疾,咳嗽,关节痛,胃痛,水肿和炎症。这项研究工作的主要目的是研究载有猪瘟的固体脂质微分散体的镇痛/抗伤害感受特性。用乙醇提取猪笼草叶片,并使用脂质基质将提取物配制成固体脂质微分散体,该脂质基质包含Precirol ® ATO 5和Softisan ® 154的合理混合物。固体脂质微分散体的组成包括形态,粒径,pH,热性质,包封效率百分数和镇痛/抗伤害感受性质的测定。所得结果表明该颗粒是球形的,尺寸为40μm至125μm。固态脂质微分散液可在90天的5-6的酸性区域内保持稳定的pH值,且变化不明显(p> 0.05)。热分析表明,猪笼草(N. laevis)被困在用于制剂的脂质基质中。固体脂质微分散体记录的最大包封效率高达88.1%。负载猪笼草的固态脂质微分散液还产生了与标准双氯芬酸钾相当的良好止痛/抗伤害感受特性。载有猪奈瑟氏球菌的固体脂质微分散液显示出良好的镇痛/抗伤害感受作用,可用于疼痛的治疗和控制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号